user

GANCICLOVIR VS GANCICLOVIR PLUS GM-CSF AS PROPHYLAXIS FOR CMV INFECTION IN ALLOGENEIC BONE-MARROW TRANSPLANTATION

被引：0
|
作者：
MACEDO, MCMA [1 ]
DULLEY, FL [1 ]
OSTRONOFF, M [1 ]
MACHADO, CM [1 ]
SILVA, ACM [1 ]
MASSUMOTO, C [1 ]
BOEHRINGER, B [1 ]
ZAMBON, E [1 ]
LOTERIO, H [1 ]
DORLHIACLLACER, PE [1 ]
CHAMONE, DF [1 ]
机构：
[1] SAO PAULO UNIV,DEP HEMATOL,FUNDACAO HEMOCTR,SAO PAULO,BRAZIL
来源：
BLOOD | 1994年 / 84卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A713 / A713
页数：1
相关论文
共 50 条
  • [1] GM-CSF AND GANCICLOVIR FOR CYTOMEGALO-VIRUS INFECTION AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    FOUILLARD, L
    GORIN, NC
    LAPORTE, JP
    EUGENEJOLCHINE, I
    ISNARD, F
    NAJMAN, A
    [J]. LANCET, 1989, 2 (8674): : 1273 - 1273
  • [2] Use of GM-CSF as prophylaxis of ganciclovir-induced. Severe bone marrow suppression
    Gomez, ER
    Gonzalez, AD
    Lopez, EM
    Calvo, PS
    Hernandez, JD
    Becerra, JT
    Rojas, VS
    [J]. REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1996, 48 (01): : 55 - 58
  • [3] DIRECTED GANCICLOVIR (DHPG) PROPHYLAXIS AGAINST CYTOMEGALOVIRUS (CMV) PNEUMONITIS IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    SCHROEDER, M
    ESSELL, J
    HARMAN, G
    HALVORSON, R
    DOLAN, M
    CALLANDER, N
    SNYDER, M
    WILKS, S
    ALLERTON, J
    THOMPSON, J
    [J]. BLOOD, 1993, 82 (10) : A425 - A425
  • [4] GM-CSF WITH GANCICLOVIR FOR THE TREATMENT OF CMV RETINITIS IN AIDS
    GROSSBERG, HS
    BONNEM, EM
    BUHLES, WC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (23): : 1560 - 1560
  • [5] PROPHYLAXIS OF CYTOMEGALOVIRUS-INFECTION WITH GANCICLOVIR IN ALLOGENEIC MARROW TRANSPLANTATION
    YAU, JC
    DIMOPOULOS, MA
    HUAN, SD
    TARRAND, JJ
    SPENCER, V
    SPITZER, G
    MENEGHETTI, CM
    WALLERSTEIN, RO
    ANDERSSON, BS
    LEMAISTRE, CF
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1991, 47 (05) : 371 - 376
  • [6] CMV prophylaxis with ganciclovir in T cell depleted allogeneic bone marrow transplantation (allo-BMT).
    Lee, CK
    Gingrich, RD
    de Magalhaes-Silverman, M
    Hohl, RJ
    [J]. BLOOD, 1998, 92 (10) : 334B - 334B
  • [7] 3 WEEKS OF GANCICLOVIR FOR CYTOMEGALOVIRAEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    SINGHAL, S
    MEHTA, J
    POWLES, R
    TRELEAVEN, J
    HORTON, C
    CARRINGTON, D
    TRYHORN, Y
    JAMESON, B
    [J]. BONE MARROW TRANSPLANTATION, 1995, 15 (05) : 777 - 781
  • [8] Efficacy of oral ganciclovir (GAN) for prevention of CMV infection following allogeneic bone marrow transplantation (BMT).
    Pineiro, L
    Skettino, S
    Tan, J
    Stempien, MJ
    [J]. BLOOD, 1997, 90 (10) : 2425 - 2425
  • [9] GM-CSF AS AN ADJUNCT TO AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    GULATI, S
    BENNETT, C
    PHILLIPS, J
    VANPOZNAK, C
    [J]. STEM CELLS, 1993, 11 (01) : 20 - 25
  • [10] PROPHYLACTIC USE OF GANCICLOVIR IN ALLOGENEIC BONE-MARROW TRANSPLANTATION - ABSENCE OF CLINICAL CYTOMEGALOVIRUS-INFECTION
    ATKINSON, K
    DOWNS, K
    GOLENIA, M
    BIGGS, J
    MARSHALL, G
    DODDS, A
    CONCANNON, A
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1991, 79 (01) : 57 - 62
12345